These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 10379420)

  • 41. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Feb; 82(2):92-101. PubMed ID: 18219438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
    Womersley K; Ripullone K; Agius M
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG; Anderson I
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacology and pharmacokinetics of citalopram and other SSRIs.
    Baumann P
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():5-11. PubMed ID: 8732438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H; Bergsholm YK; Bøhler E; Spigset O
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural basis for action by diverse antidepressants on biogenic amine transporters.
    Wang H; Goehring A; Wang KH; Penmatsa A; Ressler R; Gouaux E
    Nature; 2013 Nov; 503(7474):141-5. PubMed ID: 24121440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
    Harvey AT; Preskorn SH
    J Clin Psychopharmacol; 1996 Oct; 16(5):345-55. PubMed ID: 8889906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers.
    Alderman J; Preskorn SH; Greenblatt DJ; Harrison W; Penenberg D; Allison J; Chung M
    J Clin Psychopharmacol; 1997 Aug; 17(4):284-91. PubMed ID: 9241008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective Serotonin Reuptake Inhibitors.
    Lochmann D; Richardson T
    Handb Exp Pharmacol; 2019; 250():135-144. PubMed ID: 30838457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid.
    Tin G; Mohamed T; Shakeri A; Pham AT; Rao PPN
    ACS Chem Neurosci; 2019 Jan; 10(1):226-234. PubMed ID: 30157623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in interactions of SSRIs.
    Brøsen K
    Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S45-7. PubMed ID: 9817620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors.
    Lane RM
    Int Clin Psychopharmacol; 1996 Dec; 11 Suppl 5():31-61. PubMed ID: 9032002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of an interaction between sumatriptan and selective serotonin reuptake inhibitors.
    Leung M; Ong M
    Headache; 1995 Sep; 35(8):488-9. PubMed ID: 7591744
    [No Abstract]   [Full Text] [Related]  

  • 54. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.
    Sullivan PW; Valuck R; Saseen J; MacFall HM
    CNS Drugs; 2004; 18(13):911-32. PubMed ID: 15521793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
    Richelson E
    Mayo Clin Proc; 1997 Sep; 72(9):835-47. PubMed ID: 9294531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract.
    Caraci F; Crupi R; Drago F; Spina E
    Curr Drug Metab; 2011 Jul; 12(6):570-7. PubMed ID: 21395523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Vinnikova MA; Severtsev VV; Komarov SD; Vdovin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):57-62. PubMed ID: 35041313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.